Necessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHD

Kathleen M. Kantak; Linda P. Dwoskin

doi:10.1016/j.pbb.2016.03.009

Necessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHD

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Original language	English
Pages (from-to)	24-26
Number of pages	3
Journal	Pharmacology Biochemistry and Behavior
Volume	145
DOIs	https://doi.org/10.1016/j.pbb.2016.03.009
State	Published - Jun 1 2016

Bibliographical note

Funding Information:
National Institute on Drug Abuse grant DA011716 funded this work.

Keywords

Adolescence
Atomoxetine
Attention Deficit Hyperactivity Disorder
Cocaine
Methylphenidate
Spontaneously Hypertensive Rats
Substance use disorders
d-Amphetamine

ASJC Scopus subject areas

Biochemistry
Toxicology
Pharmacology
Clinical Biochemistry
Biological Psychiatry
Behavioral Neuroscience

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.pbb.2016.03.009

Cite this

@article{f284e7a36be945c79bd263195200d695,

title = "Necessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHD",

keywords = "Adolescence, Atomoxetine, Attention Deficit Hyperactivity Disorder, Cocaine, Methylphenidate, Spontaneously Hypertensive Rats, Substance use disorders, d-Amphetamine",

author = "Kantak, {Kathleen M.} and Dwoskin, {Linda P.}",

note = "Funding Information: National Institute on Drug Abuse grant DA011716 funded this work.",

year = "2016",

month = jun,

day = "1",

doi = "10.1016/j.pbb.2016.03.009",

language = "English",

volume = "145",

pages = "24--26",

}

TY - JOUR

T1 - Necessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHD

AU - Kantak, Kathleen M.

AU - Dwoskin, Linda P.

N1 - Funding Information: National Institute on Drug Abuse grant DA011716 funded this work.

PY - 2016/6/1

Y1 - 2016/6/1

KW - Adolescence

KW - Atomoxetine

KW - Attention Deficit Hyperactivity Disorder

KW - Cocaine

KW - Methylphenidate

KW - Spontaneously Hypertensive Rats

KW - Substance use disorders

KW - d-Amphetamine

UR - http://www.scopus.com/inward/record.url?scp=84962468002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962468002&partnerID=8YFLogxK

U2 - 10.1016/j.pbb.2016.03.009

DO - 10.1016/j.pbb.2016.03.009

M3 - Article

C2 - 27012495

AN - SCOPUS:84962468002

VL - 145

SP - 24

EP - 26

ER -

Necessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHD

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this